SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-20-000306
Filing Date
2020-02-10
Accepted
2020-02-10 16:09:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc20-112_sc13ga.htm SC 13G/A 100928
  Complete submission text file 0000905148-20-000306.txt   102340
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89137 | Film No.: 20591983
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIVERBANK HOUSE, 2 SWAN LANE LONDON X0 EC4R 3AD
Business Address RIVERBANK HOUSE, 2 SWAN LANE LONDON X0 EC4R 3AD 44 202 7144 1000
Man Group plc (Filed by) CIK: 0001637460 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A